Speakers: Emmanuel Caeymaex and Jean-Christophe Tellier

The UCB-Stanford Collaboration's goal of “Predict, Prevent and Cure”

Speakers: Euan Ashley and Iris Loew-Friedrich

At an individual level, empowered patients will be virtually connected with physicians, pharmacists and each other more than ever before through personal device data as part of the Internet of Things. How do we leverage technology to deeply understand unique patient experiences and enable personalized, precision treatments to become a reality?

Speakers: Kathleen Poston and Miguel Camargo

Biopharma research and development will be increasingly driven through partnership models, technology-derived insights and expectations of accelerated delivery. How will research questions be answered and meaningfully translated into value for patients in immunology and neurology over the next 10 years?

Speakers: Russ Altman and Dean Minor

The UCB-Stanford Collaboration's goal of “Predict, Prevent and Cure”

Speakers: Kevin Schulman and James Zackheim

At a macro level, competing forces of integrated healthcare companies, multi-sided platform consumer and tech companies, health affordability, political and economic factors including employment will mean fundamental changes to the way health systems function. How will the healthcare value framework be regulated, accessed and funded in the next decade?

Speakers: Joint Steering Committee

What new ideas, challenges, or innovative solutions were discussed? What unique opportunities are available for UCB and Stanford to work together and shape our future? How might the UCB Stanford collaboration serve as a catalyst to further explore and develop these areas?